Paul W. Boltz, Jr.


  • JD, Villanova University School of Law, 1996
  • BA, University of Pennsylvania, 1991


  • Hong Kong, Solicitor, 2003
  • New Jersey, 1996
  • Pennsylvania, 1996

Paul W. Boltz, Jr.


Paul represents U.S.-listed and pre-IPO companies based in Asia on a wide range of corporate activity and cross-border transactional work, often with a U.S. public securities aspect. He also represents issuers, underwriters and private equity sponsors in connection with initial public offerings and other capital markets transactions in the United States and Hong Kong markets, as well as multiple take-private transactions.

Paul has practiced in Hong Kong since 2000 and his clients include many of China’s leading life science and high tech companies.


  • Represented a large Chinese sovereign wealth fund in a co-investment in a top Korean consumer and household electronics company.
  • Represented a large Chinese sovereign wealth fund it its portfolio of investments held by a Fortune 50 company based in the United States. The total value of the investments was US$700 million.
  • Represented DYNAM JAPAN HOLDINGS Co., Ltd. (HKSE Main Board, stock code 06889) as its international counsel in its listing on the Main Board of the Hong Kong Stock Exchange and concurrent Reg S/Rule 144A global offering. The IPO is notable in that DYNAM is the first Japanese company to ever have a primary listing in the Hong Kong market.
  • Represented China Zenix Auto International (NYSE: ZX), China’s leading commercial vehicle wheel manufacturer, in its initial listing on the New York Stock Exchange and in its recently announced proposed restructuring.
  • Represented long-time client, Inc. (NASDAQ Global Select: NTES), one of China’s leading online game companies and internet portal operators, in a variety of corporate matters including its establishment of an onshore/offshore joint venture with Blizzard Entertainment for the operation of World of Warcraft in China and NetEase’s US$125 million convertible notes offering.
  • Represented MicroPort Scientific Corporation (HKSE Main Board, stock code 853), China’s leading minimally invasive medical device manufacturer, in its initial listing in Hong Kong and concurrent global offering.
  • Represented China GrenTech Corporation Ltd. (NASDAQ Global Select: GRRF), a mobile network communication equipment manufacturer in China, in a variety of corporate matters including an SEC-registered secondary sale of equity securities and its subsequent privatization from the U.S. markets.
  • Represent Linktone Ltd. (NASDAQ Global: LTON), a leading wireless services company, in a variety of corporate matters, including its initial public offering, and the acquisition of a majority stake in Linktone by Indonesian media conglomerate PT PT. Media Nusantara Citra Tbk.
  • Represent a number of leading private equity investors in connection with the initial public offerings in the U.S. or Hong Kong of their portfolio companies, including the NYSE IPO of TPG portfolio company ShangPharma Corp. and the Nasdaq IPO of Sequoia Capital portfolio company Sky-mobi Limited, as well as the SEC-registered secondary offering by Sequoia capital and DCM of a portion of their stake in NYSE-listed Vipshop.
  • Represented Ku6 Media Co., Ltd. and its independent special committee (formerly named Hurray! Holding Co.) (NASDAQ Global: KUTV), a leading video portal operator in China, in the acquisition of a majority stake in Ku6 by Nasdaq-listed Shanda Interactive.


  • Chambers Asia: Asia's Leading Lawyers for Business (2012-2014)
  • Chambers Global: The World’s Leading Lawyers for Business (2011-2014)




  • Presenter, “China, the Internet & Your Business: Navigating Deals in the World’s Largest and Most Complicated Internet, Market,” Licensing Executives Society - Silicon Valley Chapter seminar, Palo Alto, CA (June 2013)
  • Lead Moderator and Presenter, “Cross-Border M&A Deals: Best Practices and Worst Pitfalls. What Both the Buy- and Sell-Sides in China Need to Know,” Ropes & Gray seminar, Beijing (February 2013)
  • "Risks When Delisting from the U.S. Markets," joint Ropes & Gray and Marsh seminar, Beijing, Shanghai, Guangzhou (2012)
  • Presenter, “What Every China-Based U.S.-Listed Company Needs to Know About U.S. SEC Enforcement Actions,” Ropes & Gray webinar (June 2012)
  • “Current Trends in Offshore Listings for Health Care Companies in China,” Podcast distributed in China to industry professionals, organized by consulting firm General Biologic (December 2010)
  • “Going Private: Maximising Value in a Downmarket,” IFLR Asia M&A Summit, Hong Kong (March 2009)